References
- Epstein RA, Bobo WV, Martin PR, et al. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol. 2013;23:498–503.
- Stover MW, Davis JM. Opioids in pregnancy and neonatal abstinence syndrome. Semin Perinatol. 2015;39:561–565.
- Ramirez-Cacho WA, Flores S, Schrader RM, et al. Effect of chronic maternal methadone therapy on intrapartum fetal heart rate patterns. J Soc Gynecol Investig. 2006;13:108–111.
- Archie CL, Lee MI, Sokol RJ, et al. The effects of methadone treatment on the reactivity of the nonstress test. Obstet Gynecol. 1989;74:254–255.
- Cejtin HE, Mills A, Swift EL. Effect of methadone on the biophysical profile. J Reprod Med. 1996;41:819–822.
- Jansson LM, Dipietro JA, Velez M, et al. Maternal methadone dosing schedule and fetal neurobehaviour. J Matern Fetal Neonatal Med. 2009;22:29–35.
- Jansson LM, DiPietro J, Elko A. Fetal response to maternal methadone administration. Am J Obstet Gynecol. 2005;193:611–617.
- Salisbury AL, Coyle MG, O'Grady KE, et al. Fetal assessment before and after dosing with buprenorphine or methadone. Addiction. 2012;107:36–44.
- Schmid M, Kuessel L, Klein K, et al. First-trimester fetal heart rate in mothers with opioid addiction. Addiction. 2010;105:1265–1268.
- Szeto HH. Effects of narcotic drugs on fetal behavioral activity: acute methadone exposure. Am J Obstet Gynecol. 1983;146:211–216.
- Umans JG, Szeto HH. Effects of opiates on fetal behavioral activity in utero. Life Sci. 1983;33:639–642.
- Wittmann BK, Segal S. A comparison of the effects of single- and split-dose methadone administration on the fetus: ultrasound evaluation. Int J Addict. 1991;26:213–218.
- Wouldes TA, Roberts AB, Pryor JE, et al. The effect of methadone treatment on the quantity and quality of human fetal movement. Neurotoxicol Teratol. 2004;26:23–34.
- Macones GA, Hankins GD, Spong CY, et al. The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. Obstet Gynecol. 2008;112:661–666.
- Moore TR. The role of amniotic fluid assessment in evaluating fetal well-being. Clin Perinatol. 2011;38:33–46, v.
- Copel JA, Bahtiyar MO. A practical approach to fetal growth restriction. Obstet Gynecol. 2014;123:1057–1069.
- Committee on Obstetric Practice. Committee Opinion No. 711: opioid use and opioid use disorder in pregnancy. Obstet Gynecol. 2017;130:e81–e94.
- Anyaegbunam A, Tran T, Jadali D, et al. Assessment of fetal well-being in methadone-maintained pregnancies: abnormal nonstress tests. Gynecol Obstet Invest. 1997;43:25–28.
- Luton D, Alran S, Fourchotte V, et al. Paris heat wave and oligohydramnios. Am J Obstet Gynecol. 2004;191:2103–2105.
- Romo A, Carceller R, Tobajas J. Intrauterine growth retardation: epidemiology and etiology. Pediatr Endocrinol Rev 2009;3:332–336.